Patents Assigned to FUDAN UNIVERSITY SHANGHAI CANCER CENTER
  • Publication number: 20220314025
    Abstract: The present disclosure may disclose methods and systems for treating an object. The method may include imaging an object fixed on a positioning device using an imaging device. The method may include obtaining a plan image of the object. The method may include generating information of a region of interest (ROI) of the object based on the plan image of the object. The method may include generating a treatment plan based on the information of the ROI. The treatment plan may include a plan isocenter on the plan image. The method may further include treating a target portion of the object based on the treatment plan using a treatment device. The object may be fixed on the positioning device from a moment that the object is started to fixed on the positioning device to an end of the treatment of the target portion.
    Type: Application
    Filed: June 29, 2021
    Publication date: October 6, 2022
    Applicants: FUDAN UNIVERSITY SHANGHAI CANCER CENTER, SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.
    Inventors: Zhen ZHANG, Weigang HU, Lei YU, Jiazhou WANG, Jun ZHAO, Yifeng WANG, Jingjie ZHOU, Wei ZHANG, Xiao GU, Yige ZHANG
  • Patent number: 9862757
    Abstract: An inhibitor targeting specific complement, the inhibitor targeting specific complement is a protein, the protein has a targeted inhibition function on the complement activation, and the amino acid sequence of the protein comprises CRIg extracellular domain and complement inhibiting domain; the amino acid sequence of the protein is consist of the CRIg extracellular domain and the complement inhibiting domain connected directly, or indirectly through a linker which can connect the two domains. The preparation method of the inhibitor targeting specific complement comprises connecting the protein polypeptides of the CRIg extracellular domain and the complement inhibiting domain by gene engineering technology. The protein can be used to prepare a drug targeting inhibition of complement activation.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: January 9, 2018
    Assignee: FUDAN UNIVERSITY SHANGHAI CANCER CENTER
    Inventors: Weiguo Hu, Qian Qiao, Xin Zhang